Atlas Trials

Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?

Clinical trial NCT00578760 · UNKNOWN

Trial details

NCT number
NCT00578760
Sponsor
University Health Network, Toronto
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hearing LossOtotoxicity
Start date
2008-02-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.